83
Views
13
CrossRef citations to date
0
Altmetric
Research Article

OSTEOPONTIN EXPRESSION IN PARTICLE-INDUCED LUNG DISEASE

, , &
Pages 585-598 | Published online: 02 Jul 2009
 

Abstract

□ Osteopontin (OPN) is a secreted cytokine with cell adhesive and chemoattractive functions whose expression is induced by a variety of environmental toxicants. It has been implicated in the pathogenesis of several pulmonary granulomatous and fibrotic conditions. For these reasons the authors investigated OPN expression in experimental particle-induced lung disease using a titanium dioxide exposure model in the rat. Under exposure conditions that resulted in fibroproliferative lung disease, rats had significant increases in total lung OPN mRNA expression and increased levels of OPN protein in bronchoalveolar lavage fluid (BALF) prior to the development of lesions. OPN immunoreactivity studies of lesion development provide evidence that this multifunctional cytokine may be important in the pathogenesis of particle-induced lung disease. Findings suggest that OPN may serve as an important biomarker for particle-induced lung disease.

Notes

The current address of Jeffrey I. Everitt is GlaxoSmithKline, Research Triangle Park, North Carolina, USA.

The authors thank Ms. L. Pluta and Ms. F. Trasti for their technical assistance and Dennis House for statistical analysis. This work was supported in part by the American Chemistry Council and the Conseil Europeen des Federations de L'Industrie Chimique.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.